generics

Mylan Launches First Generic Version of Menopause Treatment
Drug Discovery and Development
Tue, 12/23/14 - 10:04 am
Mylan Labs
generics
menopause
Novartis
Vivelle-Dot
FDA clears Lannett's generic eye drug
Seeking Alpha
Thu, 12/18/14 - 06:35 pm
FDA
Lannett
generics
UCB Cancels Sale of Generic-Drug Unit to Buyout Firms
Bloomberg
Wed, 12/17/14 - 08:04 am
UCB Pharmaceuticals
M&A
generics
FDA Ruling Blocking Celebrex Generics Reversed in Win For Mylan
Bloomberg
Tue, 12/16/14 - 11:55 am
FDA
Celebrex
Pfizer
Mylan Labs
generics
Lupin
Watson Laboratories
What the AstraZeneca and Ranbaxy Pay-to-Delay Case Didn’t Tell Us
WSJ Pharmalot
Thu, 12/11/14 - 07:27 pm
AstraZeneca
Ranbaxy
pay-for-delay
generics
What a Generic Celebrex Means for Pfizer and for Actavis
24/7 Wall St
Wed, 12/10/14 - 10:52 am
generics
Celebrex
Actavis
Pfizer
Indian merger creates fifth-largest generic drugmaker
Medical Marketing and Media
Mon, 12/8/14 - 11:23 pm
India
M&A
generics
Sun Pharma
Ranbaxy
Daiichi Sankyo
AstraZeneca and Ranbaxy Win a Closely Watched Pay-to-Delay Case
WSJ Pharmalot
Mon, 12/8/14 - 12:13 pm
AstraZeneca
Ranbaxy
pay-for-delay
Nexium
generics
Sandoz loses bid to shield psoriasis drug
Yahoo/Reuters
Fri, 12/5/14 - 03:18 pm
Sandoz
psoriasis
Amgen
Enbrel
generics
AstraZeneca Fights Billions in Possible Nexium Damages
Bloomberg
Wed, 12/3/14 - 07:37 am
AstraZeneca
Nexium
generics
pay-for-delay
Ranbaxy
Actavis Launches Generic of Shire's ADHD Drug Intuniv
Yahoo/Zacks.com
Tue, 12/2/14 - 09:03 pm
Actavis
generics
Shire
ADHD
Intuniv
Patients Feel The Pinch Of Higher Generic Drug Prices
CBS
Sun, 11/30/14 - 10:21 am
generics
AstraZeneca Loses Bid to End ‘Pay-For-Delay’ Nexium Trial
Bloomberg
Mon, 11/24/14 - 12:47 pm
AstraZeneca
Ranbaxy
Nexium
generics
pay-for-delay
Ranbaxy Loses Bid to Block Rivals in Generic Drugs Fight
Bloomberg
Thu, 11/20/14 - 08:24 am
Ranbaxy
generics
FDA Cracking Down on Attempts to Delay Entry of Generic Drugs, Data Show
RAPS.org
Wed, 11/19/14 - 08:46 am
FDA
generics
FDA Delays Final Rule on Allowing Generic Drug Makers to Update Labels
WSJ Pharmalot
Tue, 11/18/14 - 10:10 am
FDA
generics
Ranbaxy Sues the FDA for Rescinding Approval of two Generic Drugs
WSJ Pharmalot
Tue, 11/18/14 - 08:29 am
Ranbaxy
generics
FDA
Valcyte
Nexium
DOJ Investigation into Generic Pharmaceutical Pricing Signals Potential Criminal Exposure
law.com
Sat, 11/15/14 - 09:46 am
generics
legal
Justice Department Probes Generic Competition After Price Hike Reports
WSJ Pharmalot
Mon, 11/10/14 - 11:00 am
DOJ
generics
Impax Laboratories
Lannett
UCB to Sell U.S. Generic Unit to Advent, Avista Capital
Bloomberg
Fri, 11/7/14 - 07:48 am
UCB Pharmaceuticals
M&A
generics
Advent International
Avista Capital

Pages